Skip to main content

Cefdinir Pregnancy and Breastfeeding Warnings

Cefdinir is also known as: Omnicef, Omnicef Omni-Pac

Medically reviewed by Last updated on Jan 4, 2021.

Cefdinir Pregnancy Warnings

Cefdinir has been assigned to pregnancy category B by the FDA. Animal studies have revealed evidence of maternal toxicity (decreased body weight gain) and decreased fetal body weight. There are no controlled data in human pregnancy. Cefdinir should be given during pregnancy only if need is clearly established.

See references

Cefdinir Breastfeeding Warnings

Following administration of single 600 mg doses, cefdinir has not been detected in human breast milk. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.

See references

References for pregnancy information

  1. "Product Information. Omnicef (cefdinir)." Parke-Davis, Morris Plains, NJ.

References for breastfeeding information

  1. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  2. "Product Information. Omnicef (cefdinir)." Parke-Davis, Morris Plains, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.